CD4 and schizophrenia: We were therefore motivated to test the mechanistically specific hypotheses that there would be abnormal expression of dopamine receptors by peripheral CD4+ T cells in clozapine-treated patients with schizophrenia; and that immune cell sub-classes in the CD4+ T cell lineage would be associated with individual differences in dopamine receptor expression.